Vietnamese pharma firm Bidiphar sets $13 mln pre-tax profit target
Vietnamese pharma major Binh Dinh Pharmaceutical Medical Equipment JSC (Bidiphar) has set 2024 revenue and pre-tax profit targets of VND2,000 billion ($79.9 million) and VND320 billion ($12.78 million), respectively.
Companies - Mon, Dec 22, 2021 | 11:30 am GMT+7
- Editor’s Picks
-
LG’s chemicals arm records modest 2023 profits in Vietnam
-
Firms with 500,000 kWh per month minimum consumption to become DPPA buyer: draft rule
-
SCG aims to fire up $5.4 bln Long Son Petrochemicals Complex in August
-
Thailand Kasikornbank’s Vietnam branch sees 2023 loss widen to $7.4 mln
-
AG&P LNG to start operating southern Vietnam LNG terminal in Sept
- Most Read
1
Investors flock to central Vietnam for renewable energy projects
Energy - Update 2 day ago
3
4
Vietnam welcomes Chinese high-tech investments: PM
Industries - Update 1 day ago
5
- Editor’s Picks
-
LG’s chemicals arm records modest 2023 profits in Vietnam
-
Firms with 500,000 kWh per month minimum consumption to become DPPA buyer: draft rule
-
SCG aims to fire up $5.4 bln Long Son Petrochemicals Complex in August
-
Thailand Kasikornbank’s Vietnam branch sees 2023 loss widen to $7.4 mln
-
AG&P LNG to start operating southern Vietnam LNG terminal in Sept
Not found block 'box_opinion'
